跳到主要內容

研究成果

2019年論文發表

  1. Chang KC, Chang MH, Lee CN, Chang CH, Wu JF, Ni YH, Wen WH, Shyu MK, Lai MW, Chen SM, Hu JJ, Lin HH, Hsu JJ, Mu SC, Lin YC, Liu CJ, Chen DS, Lin LH, Chen HL; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Decreased neonatal hepatitis B virus (HBV)viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers. Aliment Pharmacol Ther. 2019 Aug;50(3):306-316
  2. Chang KV, Chen JD, Wu WT, Huang KC, Han DS. Association of loss of muscle mass with mortality in liver cirrhosis without or before liver transplantation A systematic review and meta-analysis. Medicine (Baltimore). 2019 Mar;98(9):e14373.
  3. Chang KV, Chen JD, Wu WT, Huang KC, Lin HY, Han DS. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis. J Formos Med Assoc. 2019 Apr;118(4):833-842.
  4. Chang MH, Fischler B, Blauvelt B, Ciocca M, Dhawan A, Ekong U, Ni YH, Porta G, Sibal A, DAgostino D, Wirth S, Morhan N, Schwarz KB; and the FISPGHAN Hepatitis B Study Group. Survey of Impediments to Prevention of Mother-to-Infant Transmission of Hepatitis B Virus by International Societies. J Pediatr Gastroenterol Nutr. 2019 Dec;69(6):648-654
  5. Chen HL, Li HY, Wu JF, Wu SH, Chen HL, Yang YH, Hsu YH, Liou BY, Chang MH, Ni YH. Panel-Based Next-Generation Sequencing for the Diagnosis of Cholestatic Genetic Liver Diseases: Clinical Utility and Challenges. J Pediatr. 2019 Feb;205:153-9.
  6. Chen HL, Ni YH, Chen PJ, Chang MH. Antiviral treatment for hepatitis B in infancy: Still an issue for debate. J Hepatol. 2019 Dec;71(6):1264-1265.
  7. Chen HS, Ho MC, Hu RH, Wu JF, Chen HL, Ni YH, Hsu HY, Jeng YM, Chang MH. Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation. J Formos Med Assoc. 2019 Sep;118(9):1362-1368
  8. Chen HS, Wu JF, Chen HL, Ni YH. Does one-man method better than two-man method for colonoscopy insertion in children? J Formos Med Assoc. 2019 Nov;118(11):1546-1550
  9. Chen HS, Wu JF, Su TH, Chen HL, Hsu HY, Xia NS, Chen PJ, Chang MH. Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level. Hepatology. 2019 Dec;70(6):1903-1912.
  10. Chen LH, Huang SY, Huang KC, Hsu CC, Yang KC, Li LA, Chan CH, Huang HY. Lactobacillus paracasei PS23 decelerated age-related muscle loss by ensuring mitochondrial function in SAMP8 mice. Aging (Albany NY). 2019 Jan 29;11(2):756-770.
  11. Chen YT, Tseng PH, Tseng FY, Chi YC, Han DS, Yang WS. The serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndrome. PLoS One. 2019 Feb 14;14(2):e0212341.
  12. Cheng YW, Chen KW, Kuo HC, Kuo CH, Lin WH, Chen PJ, Yeh SH. Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes. Int J Obes (Lond). 2019 Dec;43(12):2469-2479.
  13. Chien MM, Chang MH, Chang KC, Lu FT, Chiu YC, Chen HL, Ni YH, Hsu HY, Wu JF. Prognostic parameters of pediatric acute liver failure and the role of plasma exchange. Pediatr Neonatol. 2019 Aug;60(4):389-395
  14. Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF. Taiwan consensus statement on the management of chronic hepatitis B. J Formos Med Assoc 2019 Jan;118(1 Pt 1):7-38.
  15. Chou CH, Ho CM, Lai SL, Chen CN, Wu YM, Shun CT, Wen WF, Lai HS. B-cell activating factor enhances the angiogenesis of hepatocytes via B-cell CLL/lymphoma 10/nuclear factor-kappa B signaling during liver regeneration. Int J Mol Sci. 2019 Oct 10;20(20).
  16. Chung YE, Chen HC, Chou HCL, Chen IM, Lee MS, Chuang LC, Liu YW, Lu ML, Chen CH, Wu CH, Huang MC, Liao SC, Ni YH, Lai MS, Shih WL, Kuo PH. Exploration of microbiota targets for major depressive disorder and mood related traits. J Psychiatr Res. 2019 Apr;111:74-82
  17. Ho CM, Chen HL, Hu RH, Lee PH. Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective. Therapeutic Advances in Medical Oncology 2019 Apr; 11; 1758835919843463
  18. Ho CM, Chen YH, Ho SL, Chen HY, Chien CS, Chen JC, Hsiao CC, Chen HL, Hu RH, Shih DT, Lee PH. Therapeutic efficacy of adipose-derived stromal vascular fraction cells is associated with CD34 positivity in acute-on-chronic liver failure. Cytotherapy 2019 May; 21(5):561-5.
  19. Ho CM, Ho SL, Jeng YM, Lai YS, Chen YH, Lu SC, Chen HL, Chang PY, Hu RH, Lee PH. Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease. Journal of Inflammation 2019 Apr; 16(1):7
  20. Ho CM, Hu RH. Comment on “Is it time to abandon the Milan criteria?” Ann Surg. 2019 Dec;270(6):e85.
  21. Ho CM, Huang YM, Hu RH, Wu YM, Ho MC, Lee PH. Revisiting donor risk over two decades of single-center experience: More attention on the impact of overweight. Asian Journal of Surgery 2019 Jan; 42(1):172-9.
  22. Ho CM, Tai HC. Invasive mold infection of the renal graft. International Medicine 2019;1(4):250-1.
  23. Hsiao CY, Chen PD, Huang KW. A Prospective Assessment of the Diagnostic Value of Contrast-Enhanced Ultrasound, Dynamic Computed Tomography and Magnetic Resonance Imaging for Patients with Small Liver Tumors. J Clin Med. 2019 Sep 1;8(9):1353.
  24. Hsiao CY, Ho CM, Wu YM, Ho MC, Hu RH, Lee PH. Biliary Complication in Pediatric Liver Transplantation: a Single-Center 15-Year Experience. Journal of Gastrointestinal Surgery 2019 Apr; 23(4):751-9.
  25. Hsiao CY, Teng X, Su TH, Lee PH, Kao JH, Huang KW. Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection. Clin Res Hepatol Gastroenterol. 2019 May 7. pii: S2210-7401(19)30093-2.
  26. Hsu CT, Chang MH, Ho MC, Chang HH, Lu MY, Jou ST, Ni YH, Chen HL, Hsu HY, Wu JF. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan. J Formos Med Assoc. 2019 Nov;118(11):1537-1545
  27. Hsu HY, Chang MH. Hepatitis B Virus Infection and the Progress toward its Elimination. J Pediatr. 2019 Feb;205:12-20.
  28. Hsu SJ, Chiu MC, Fang YJ, Yang TH, Yu JJ, Chen CC, Kuo CC, Lee JY, Chen CH, Chen DS, Kao JH. Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C. J Formos Med Assoc. 2019 Aug;118(8):1187-1192.
  29. Hsu SJ, Yang SS, Kao JH. Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction? J Formos Med Assoc. 2020 Jan;119(1 Pt 1):3-11.
  30. Hsu YC, Tseng CH, Kao JH. Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done. Clin Gastroenterol Hepatol. 2019 Apr;17(5):1000-1001.
  31. Hu J, Lin YY, Chen PJ, Watashi K, Wakita T. Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development. Gastroenterology. 2019 Jan;156(2):338-354.
  32. Hu KC, Wu MS, Chu CH, Wang HY, Lin SC, Liu CC, Su TH, Liao WC, Chen CL, Liu CJ, Shih SC. Decreased Colorectal Adenoma Risk after Helicobacter pylori Eradication: A Retrospective Cohort Study. Clin Infect Dis 2019 May 30;68(12):2105-2113.
  33. Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, Huang JF, Chuang WL, Yu ML. An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions. J Infect Dis. 2019 Jul 19;220(4):557-566.
  34. Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, Hayashi J, Tseng CH, Yasuda S, Tran S, Kam L, Henry L, Jeong JY, Nomura H, Park SH, Nakamuta M, Huang JF, Tai CM, Lo GH, Lee MH, Yang HI, Kao JH, Tamori A, Eguchi Y, Ueno Y, Furusyo N, Tanaka Y, Yu ML, Nguyen MH; REAL-C Investigators. Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. Hepatol Int. 2019 Sep;13(5):587-598.
  35. Huang KW, Jayant K, Lee PH, Yang PC, Hsiao CY, Habib N, Sodergren MH. Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma. Journal of Clinical Medicine. 2019 March;8(3):E385.
  36. Huang KW, Reebye V, Czysz K, Ciriello S, Dorman S, Reccia I, Lai HS, Peng L, Kostomitsopoulos N, Nicholls J, Habib RS, Tomalia DA, Sætrom P, Wilkes E, Cutillas P, Rossi JJ, Habib NA. Liver activation of Hepatocellular Nuclear Factor-4α by small activating RNA rescues dyslipidemia and improves metabolic profile. Mol Ther Nucleic Acids. 2019 Nov 21;19:361-370.
  37. Huang MH, Chang SY, Liu CH, Cheng A, Su LH, Liu WC, Su YC, Sun HY, Hung CC, Chang SC. HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan. Liver Int. 2019 Oct;39(10):1860-1867
  38. Hung WL, Wu JF, Ni YH, Chen HL, Chiang CL, Chang MH, Hsu HY. Occult hepatitis B virus and surface antigen mutant infection in healthy vaccinated cohorts and children with various forms of hepatitis andmultiple transfusions. Liver Int. 2019 Jun;39(6):1052-1061
  39. Indolfi G, Easterbrook P, Dusheiko G, El-Sayed MH, Jonas MM, Thorne C, Bulterys M, Siberry G, Walsh N, Chang MH, Meyers T, Giaquinto C, Wirth S, Chan PL, Penazzato M. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019 Jun;4(6):477-487.
  40. Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, Bulterys M, Chan PL, El-Sayed MH, Giaquinto C, Jonas MM, Meyers T, Walsh N, Wirth S, Penazzato M. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019 Jun;4(6):466-476.
  41. Jeng WJ, Hsu YC, Su TH, Chen CH. Deliberations more than a cut‐off HBsAg value for Nuc cessation. Hepatology. 2019 Feb 22. [Epub ahead of print]
  42. Jeng WJ, Hsu YC, Su TH, Chen CH. Letter to the Editor: Deliberations More Than a Cut-off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessation. Hepatology. 2019 Oct;70(4):1488-1489. doi: 10.1002/hep.30576.
  43. Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Kadir Dokmeci A, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, Kao JH, Ooka Y, Yokosuka O, Sarin SK, Omata M. APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatol Int. 2019 Nov;13(6):649-661.
  44. Kao JH, Berg T. Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop? Gut. 2019 Dec;68(12):2105-2106.
  45. Kao JH, Lin CY, Chuang WL, Cheng YY, Hu JY, Liang WK, Friebe P, Palmer S, Huang CS. Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping. Diagn Microbiol Infect Dis. 2019 Aug;94(4):344-348.
  46. Lai MW, Chang MH. Updates in the management of hepatitis B in children. Expert Rev Gastroenterol Hepatol. 2019 Nov;13(11):1065-1076.
  47. Lee CT, Tung YC, Hwu WL, Shih JC, Lin WH, Wu MZ, Kuo KT, Yang YL, Chen HL, Chen M, Su YN, Jong YJ, Liu SY, Tsai WY, Lee NC. Mosaic paternal haploidy in a patient with pancreatoblastoma and Beckwith-Wiedemann spectrum. Am J Med Genet A. 2019 Sep;179(9):1878-1883.
  48. Lee CZ, Peng SS, Lee CS, Chen HL, Ni YH, Chang MH, Wu JF. Transient elastography correlated with diffusion-weighted magnetic resonance imaging and cholestatic complications. J Formos Med Assoc. 2019 Nov;118(11):1522-1527
  49. Lee YH, Lu CW, Huang CT, Chang HH, Yang KC, Kuo CS, Chang YK, Hsu CC, Huang KC. Impact of a home health care program for disabled patients in Taiwan A nationwide population-based cohort study. Medicine (Baltimore). 2019 Feb;98(7):e14502.
  50. Li CL, Li CY, Lin YY, Ho MC, Chen DS, Chen PJ, Yeh SH. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region. Hepatology. 2019 Feb;69(2):498-512.
  51. Li YT, Wu HL, Kao JH, Cheng HR, Ho MC, Wang CC, Chen PJ, Chen DS, Liu CJ. Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates with Early Recurrence and Aggressive Features of HBV-Associated HCC. Hepatology 2019 Jul;70:184-197.
  52. Liao FM, Chang MH, Ho MC, Chen HL, Ni YH, Hsu HY, Wu JF. Resistance index of hepatic artery can predict anastomotic biliary complications after liver transplantation in children. J Formos Med Assoc 2019; 118(1 pt 2):209-14.
  53. Liao SH, Su TH, Jeng YM, Liang PC, Chen DS, Chen CH, Kao JH. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma. Hepatology. 2019 Jan;69(1):209-221.
  54. Liao YY, Yeh CK, Huang KC, Tsui PH, Yang KC. Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease. Sci Rep. 2019 May 28;9(1):7922.
  55. Lin HH, Tseng TC, Kao JH. Large and middle hepatitis B surface antigen: the lower the better? Gut. 2019 Feb;68(2):376-377.
  56. Lin IW, Chang HH, Lee YH, Wu YC, Lu CW, Huang KC. Blood sugar control among type 2 diabetic patients who travel abroad A cross sectional study. Medicine (Baltimore). 2019 Mar;98(13):e14946.
  57. Liu CH, Shih YL, Yang SS, Lin CL, Fang YJ, Cheng PN, Chen CY, Peng CY, Hsieh TY, Chiu YC, Su TH, Liu CJ, Yang HC, Chen PJ, Chen DS, Kao JH. Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. J Gastroenterol Hepatol. 2019 Nov;34(11):1977-1983.
  58. Liu CH, Su TH, Liu CJ, Hong CM, Yang HC, Tseng TC, Chen PJ, Chen DS, Kao JH. Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection J Gastroenterol Hepatol. 2019 Sep;34(9):1620-1625.
  59. Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study. J Formos Med Assoc. 2019 Jun;118(6):1014-1023.
  60. Liu CJ, Tseng KC, Lo CC, Tseng IH, Cheng PN. Limited drug-drug interaction of Elbasvir/Grazoprevir for chronic hepatitis C. J Formos Med Assoc 2019 Oct 5. pii: S0929-6646(19)30666-7.
  61. Liu CJ, Tseng TC, Yang WT, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. Profile and Value of FIB-4 in Patients with Dual Chronic Hepatitis C and B. J Gastroenterol Hepatol 2019 Feb;34(2):410-417.
  62. Liu HH, Lin YC, Chung CS, Liu K, Chang YH, Yang CH, Chen Y, Ni YH, Chang PF. Integrated counts of carbohydrate-active protein domains as metabolic readouts to distinguish probiotic biology and human fecal metagenomes. Sci Rep. 2019 Nov 14;9(1):16836
  63. Liu J, Hu HH, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, Yuan Q, Xia NS, Sugiyama M, Nishida N, Mizokami M, Chen CJ, Chen PJ, Yang HI. Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1413-1415.
  64. Lu CW, Chang HH, Yang KC, Chiang CH, Yao CA, Huang KC. Gender Differences with Dose-Response Relationship between Serum Selenium Levels and Metabolic SyndromeA Case-Control Study Nutrients. 2019 Feb 24;11(2). pii: E477.
  65. Lu CW, Lee YH, Pan YH, Chang HH, Wu YC, Sheng WH, Huang KC. Tuberculosis among migrant workers in Taiwan. Global Health. 2019 Feb 28;15(1):18.
  66. Pavlovic V, Yang L, Chan HL, Hou J, Janssen HL, Kao JH, Lampertico P, Peng CY, Piratvisuth T, Thompson AJ, Wedemeyer H, Wei L, Wat C. Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data. Antivir Ther. 2019;24(2):133-140.
  67. Su TH, Liao SH, Hong CM, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen PJ, Chen DS, Chen CL, Adhoute X, Bourlière M, Kao JH. NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging. J Gastroenterol Hepatol 2019 Dec;34(12):2179-2186
  68. Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Chronic hepatitis B associates with an increased risk of B-cell non-Hodgkin’s lymphoma and multiple myeloma. Aliment Pharmacol Ther 2019 Mar;49(5):589-598.
  69. Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection. Aliment Pharmacol Ther 2019 Feb;49(3):331-339.
  70. Su TH, Tseng TC, Liu CJ, Chou SW, Liu CH, Yang HC, Chen PJ, Chen DS, Chen CL, Kao JH. Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.  Int J Cancer. 2019 Dec 19. doi: 10.1002/ijc.32840.
  71. Su WJ, Chen SF, Yang CH, Chuang PH, Chang HF, Chang MH. The Impact of Universal Infant Hepatitis B Immunization on Reducing the Hepatitis B Carrier Rate in Pregnant Women. J Infect Dis. 2019 Aug 30;220(7):1118-1126
  72. Tsai DH, Lee MH, Chen DS, Liaw YF, Yang PC, Huang YH, Chen CJ. Taiwan's health-care system and administration are independent of China. Lancet. 2019 Oct 26;394(10208):1516.
  73. Tseng FY, Chen YT, Chi YC, Chen PL, Yang WS. Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: A prospective observational study. Medicine (Baltimore). 2019 Mar;98(11):e14862.
  74. Tseng SM, Li C, Ho CM. Pneumatosis cystoides intestinalis: Not uncommon cause of free air in acute abdomen. Journal of Visceral Surgery 2019 Apr; 156(2):177-8.
  75. Tseng TC, Liu CJ, Hsu CY, Hong CM, Su TH, Yang WT, Chen CL, Yang HC, Huang YT, Fang-Tzu Kuo S, Liu CH, Chen PJ, Chen DS, Kao JH. High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load. Gastroenterology 2019 Aug 27. pii: S0016-5085(19)41248-1.
  76. Tseng TC, Shih YF, Liu CJ. A simple non-invasive test for ruling out cirrhosis in chronic hepatitis B. Lancet Gastroenterol Hepatol 2019 Jul;4(7):495-496.
  77. Tsou HH, Yang HC, Hsiao CF, Hsiung CA, Liu TW, Chuang MH, Wu HY, Hsu YT, Tsui CW, Chen PJ, Cheng AL, Hsu C; Taiwan Cooperative Oncology Group. Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection. J Formos Med Assoc. 2019 Jun 21. pii: S0929-6646(19)30139-1.
  78. Wang CC, Cheng PN, Kao JH. Systematic review: chronic viral hepatitis and metabolic derangement. Aliment Pharmacol Ther. 2020 Jan;51(2):216-230.
  79. Wang CC, Kao JH. The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogue Cessation Among Asian Chronic Hepatitis B Patients: Friend or Foe? Hepatology. 2019 Apr;69(4):1843.
  80. Wang YH, Chuang YH, Wu CF, Jan MC, Wu WJ, Lin CL, Liu CJ, Yang YC, Chen PJ, Lin SM, Tsai MH, Huang YW, Yu MW. Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase. Hepatology 2019;69:1412-1425.
  81. Wei L, Pavlovic V, Bansal AT, Chen X, Foster GR, He H, Kao JH, Lampertico P, Liaw YF, Motoc A, Papatheodoridis GV, Piratvisuth T, Plesniak R, Wat C. Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B. J Viral Hepat. 2019 Sep;26(9):1040-1049.
  82. Wu JF, Jeng YM, Chen HL, Ni YH, Hsu HY, Chang MH. Quantification of serum matrix metallopeptide 7 levels may assist in the diagnosis and predict the outcome for patients with biliary atresia. J Pediatr. 2019 May;208:30-37.e1
  83. Wu JW,Tseng TC. Make platelet count great again: Direct-acting antiviral agent therapy in patients with chronic hepatitis C. Advances in digestive medicine 2019 Sep;6(3):91-92
  84. Wu LL, Peng WH, Wu HL, Miaw SC, Yeh SH, Yang HC, Liao PH, Lin JS, Chen YR, Hong YT, Wang HY, Chen PJ, Chen DS. Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice. Hepatology. 2019 Jun;69(6):2364-2380.
  85. Wu SH, Hsu JS, Chen HL, Chien MM, Wu JF, Ni YH, Liou BY, Ho MC, Jeng YM, Chang MH, Chen PL, Chen HL. Plectin Mutations in Progressive Familial Intrahepatic Cholestasis. Hepatology. 2019 Dec;70(6):2221-2224
  86. Yang HC, Kao JH. Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus. Gut. 2019 Nov;68(11):2095.
  87. Yang HI, Yeh ML, Wong GL, Peng CY, Chen CH, Trinh HN, Cheung KS, Xie Q, Su TH, Kozuka R, Lee DH, Ogawa E, Zhao C, Ning HB, Huang R, Li J, Zhang JQ, Ide T, Xing H, Iwane S, Takahashi H, Wong C, Wong C, Lin CH, Hoang J, le A, Henry L, Toyoda H, Ueno Y, Gane EJ, Eguchi Y, Kurosaki M, Wu C, Liu C, Shang J, Furusyo N, Enomoto M, Kao JH, Yuen MF, Yu ML, Nguyen MH. REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. J Infect Dis. 2019 Sep 24. pii: jiz477. doi: 10.1093/infdis/jiz477
  88. Yang PJ, Cheng MF, Yang WS, Tsai MS, Lee PC, Chen CN, Lin MT, Tseng PH. A Higher Preoperative Glycemic Profile Is Associated with Rapid Gastric Emptying After Sleeve Gastrectomy for Obese Subjects. Obes Surg. 2019 Feb;29(2):569-578.
  89. Yeh PT, Huang YH, Chang SW, Wang LC, Yang CM, Yang WS, Lin CW, Yang CH. Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal Model. Curr Eye Res. 2019 Mar;44(3):294-302.
  90. Yeh PT, Wang LC, Chang SW, Yang WS, Yang CM, Yang CH. Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat Model. Curr Eye Res. 2019 Jun 3:1-12.
  91. Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, Kwak MS, Park YM, Fung JYY, Buti M, Rodríguez M, Treeprasertsuk S, Preda CM, Ungtrakul T, Charatcharoenwitthaya P, Li X, Li J, Zhang J, Le MH, Wei B, Zou B, Le A, Jeong D, Chien N, Kam L, Lee CC, Riveiro-Barciela M, Istratescu D, Sriprayoon T, Chong Y, Tanwandee T, Kobayashi M, Suzuki F, Yuen MF, Lee HS, Kao JH, Lok AS, Wu CY, Nguyen MH. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis. Gastroenterology. 2019 Feb;156(3):635-646.
  92. Yoon S, Huang KW, Andrikakou P, Vasconcelos D, Swiderski P, Reebye V, Sodergren M, Habib N, Rossi JJ. Targeted delivery of C/EBPα-saRNA by RNA aptamers shows anti-tumor effects in a mouse model of advanced pancreatic ductal adenocarcinoma. Molecular Mol Ther Nucleic Acids. 2019 Dec 6;18:142-154.
  93. Yu LY, Hu KC, Liu CJ, Hung CL, Bair MJ, Chen MJ, Wang HY, Wu MS, Shih SC, Liu CC. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque. Medicine 2019 Mar;98(9):e14672
  94. Yu ML, Hung CH, Huang YH, Peng CY, Lin CY, Cheng PN, Chien RN, Hsu SJ, Liu CH, Huang CF, Su CW, Huang JF, Liu CJ, Kao JH, Chuang WL, Chen PJ, Chen DS. Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions. J Formos Med Assoc 2019;118:556-564.
  95. Zhang TY, Guo XR, Wu YT, Kang XZ, Zheng QB, Qi RY, Chen BB, Lan Y, Wei M, Wang SJ, Xiong HL, Cao JL, Zhang BH, Qiao XY, Huang XF, Wang YB, Fang MJ, Zhang YL, Cheng T, Chen YX, Zhao QJ, Li SW, Ge SX, Chen PJ, Zhang J, Yuan Q, Xia NS. A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice. Gut. 2019 Mar 29. pii: gutjnl-2018-317725.
  96. Zhao X, Reebye V, Hitchen P, Fan J, Jiang H, Sætrom P, Rossi J, Habib NA, Huang KW. Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma. Oncogene. 2019. January; 38(18): 3446–3457.
  97. Zhou J, Li H, Xia X, Herrera A, Pollock N, Reebye V, Sodergren MH, Dorman S, Littman BH, Doogan D, Huang KW, Habib R, Blakey D, Habib NA, Rossi JJ. Anti-inflammatory activity of MTL-CEBPA, a Small Activating RNA drug, in LPS- stimulated monocytes and humanized mice. Molecular Therapy. 2019. May;27(5):999-1016.

新聞亮點

新聞報紙